yingweiwo

Src

Src

Src related products

Structure Cat No. Product Name CAS No. Product Description
FYN Y531F Recombinant Human Active Protein Kinase V118909 FYN Y531F Recombinant Human Active Protein Kinase FYN Y531F recombinant human active protein kinase is an oncogene that directly activates YANK2 by phosphorylation of the Y110 site.
Hck-IN-3 V116671 Hck-IN-3 Hck-IN-3 (compound 2D) is an orally effective HCK inhibitor (KD = 3.92 μM).
Hibarimicin A V137354 Hibarimicin A 208588-76-5 Hibarimicin A is a tyrosine kinase inhibitor found in the subspecies *Hibaria* of *Microsporum roseum*.
Hibarimicin C V137356 Hibarimicin C 208588-83-4 Hibarimicin C is a tyrosine kinase inhibitor.
Hibarimicin D V137357 Hibarimicin D 208588-87-8 Hibarimicin D is a tyrosine kinase inhibitor.
LCK degrader-3 V109967 LCK degrader-3 3095032-59-7 LCK Degrader-3 (Compound 20) is a CRBN-based LCK molecular glue degrader.
MRT-10350 V140419 MRT-10350 MRT-10350 is a cereblon-based HCK molecular adhesive degrader.
pp2 V0667 PP2 (AG1879) 172889-27-9 PP2 (also known as AG 1879; AG-1879) a novel, potent,reversible, and ATP-competitiveand selective Src family kinase inhibitor with potential anticancer activity.
Saracatinib-d3 V94145 Saracatinib-d3 2200301-36-4 Saracatinib-d3 (AZD0530-d3) (ZG5129) is a deuterated derivative of Saracatinib.
SKLB646 V98063 SKLB646 1970149-05-3 SKLB646 is an oral multi-targeted kinase inhibitor.
UM-164 V3287 UM-164 903564-48-7 UM-164, a dasatinib analogue, isa potent and dual inhibitor of the Src/p38 kinase with potential anticancer activity for Triple-Negative Breast Cancer (TNBC).
Contact Us